Low molecular weight heparin vs unfractionated heparin
Recurrent VTE · patients with cancer with venous thromboembolism
Low molecular weight heparin showed no clear difference in recurrent VTE compared with unfractionated heparin (low certainty).
1 finding from 1 review
- Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes onlyRR 0.69 [0.27, 1.76]3 studies · 422 participantsLow